Detalhe da pesquisa
1.
Implementing DPYD*2A Genotyping in Clinical Practice: The Quebec, Canada, Experience.
Oncologist
; 26(4): e597-e602, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33274825
2.
First-Line Nivolumab Plus Ipilimumab in Advanced Non-Small-Cell Lung Cancer (CheckMate 568): Outcomes by Programmed Death Ligand 1 and Tumor Mutational Burden as Biomarkers.
J Clin Oncol
; 37(12): 992-1000, 2019 04 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-30785829
3.
A four-arm, randomized, multicenter phase II trial of oxaliplatin combined with varying schedules of 5-fluorouracil as first-line therapy in previously untreated advanced colorectal cancer.
Clin Colorectal Cancer
; 7(2): 134-9, 2008 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-18501073
4.
Reflex Testing for Germline BRCA1, BRCA2, PALB2, and ATM Mutations in Pancreatic Cancer: Mutation Prevalence and Clinical Outcomes From Two Canadian Research Registries.
JCO Precis Oncol
; 2: 1-16, 2018 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-35135108
5.
Population pharmacokinetics of troxacitabine, a novel dioxolane nucleoside analogue.
Clin Cancer Res
; 12(7 Pt 1): 2158-65, 2006 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16609029
6.
Randomized Phase II Study of the X-linked Inhibitor of Apoptosis (XIAP) Antisense AEG35156 in Combination With Sorafenib in Patients With Advanced Hepatocellular Carcinoma (HCC).
Am J Clin Oncol
; 39(6): 609-613, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-24977690
7.
Phase I and pharmacokinetic study of novel L-nucleoside analog troxacitabine given as a 30-minute infusion every 21 days.
J Clin Oncol
; 20(10): 2567-74, 2002 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-12011137
8.
Phase II study of troxacitabine, a novel dioxolane nucleoside analog, in patients with refractory leukemia.
J Clin Oncol
; 20(3): 656-64, 2002 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-11821445
9.
Troxacitabine, an L-stereoisomeric nucleoside analog, on a five-times-daily schedule: a phase I and pharmacokinetic study in patients with advanced solid malignancies.
J Clin Oncol
; 20(1): 96-109, 2002 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-11773159
10.
Activity and safety of the antiestrogen EM-800, the orally active precursor of acolbifene, in tamoxifen-resistant breast cancer.
J Clin Oncol
; 22(5): 864-71, 2004 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-14990642
11.
Species differences in troxacitabine pharmacokinetics and pharmacodynamics: implications for clinical development.
Clin Cancer Res
; 10(22): 7692-702, 2004 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-15570003
12.
Complementary antineoplastic activity of the cytosine nucleoside analogues troxacitabine (Troxatyl) and cytarabine in human leukemia cells.
Cancer Chemother Pharmacol
; 52(6): 497-506, 2003 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-12955470
13.
[Troxacitabine]. / La troxacitabine.
Bull Cancer
; 91(3): 213-8, 2004 Mar.
Artigo
em Francês
| MEDLINE | ID: mdl-15171046
14.
Phase I trial of AEG35156 an antisense oligonucleotide to XIAP plus gemcitabine in patients with metastatic pancreatic ductal adenocarcinoma.
Am J Clin Oncol
; 36(3): 239-43, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22441342
15.
Addition of AEG35156 XIAP antisense oligonucleotide in reinduction chemotherapy does not improve remission rates in patients with primary refractory acute myeloid leukemia in a randomized phase II study.
Clin Lymphoma Myeloma Leuk
; 11(5): 433-8, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21729686
16.
Phase I trial of AEG35156 administered as a 7-day and 3-day continuous intravenous infusion in patients with advanced refractory cancer.
J Clin Oncol
; 27(10): 1660-6, 2009 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19237630
17.
Phase I and pharmacokinetic study of cisplatin and troxacitabine administered intravenously every 28 days in patients with advanced solid malignancies.
Cancer Chemother Pharmacol
; 65(1): 167-75, 2009 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-19449006
18.
Phase I/II trial of AEG35156 X-linked inhibitor of apoptosis protein antisense oligonucleotide combined with idarubicin and cytarabine in patients with relapsed or primary refractory acute myeloid leukemia.
J Clin Oncol
; 27(28): 4741-6, 2009 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19652057